E-health Tool for Management of Chronic Pain Patients. (e-DOL)

September 18, 2020 updated by: University Hospital, Clermont-Ferrand

Evaluation of the Feasibility of an E-health Tool in the Follow-up and Characterization of Chronic Pain Patients.

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care.

In order to allow the characterization and a personalized follow-up of chronic pain patients, Investigator has created e-DOL, a smartphone application for patients and a web platform for physicians. The purpose of this study is to evaluate the feasibility and clinical interest of an e-Health smartphone application for the characterization and follow-up of chronic pain patients..

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This first clinical study will assess the acceptability of the tool both by caregivers at the 13 pain clinics and by a panel of 300 patients followed for 6 months. Based on the results of the study (end 2019), investigator will improve the tool in a version 2.0, which will then be evaluated in a large impact study, measuring the intrinsic therapeutic effect of eDOL.

Study Type

Observational

Enrollment (Actual)

113

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France
        • CHU Amiens
      • Bayeux, France
        • Ch Bayeux
      • Clermont-Ferrand, France, 63003
        • CHU Clermont-Ferrand
      • Grenoble, France
        • CHU Grenoble
      • Limoges, France
        • Chu Limoges
      • Lyon, France
        • Hospices Civils de Lyon
      • Nîmes, France
        • CHU Nîmes
      • Paris, France
        • AP-HP Ambroise Pare
      • Paris, France
        • AP-HP Cochin
      • Paris, France
        • AP-HP Lariboisiere
      • Rouen, France
        • CHU Rouen
      • Toulouse, France
        • CHU Toulouse
      • Voiron, France
        • CH Voiron

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 83 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with chronic pain

Description

Inclusion Criteria:

  • All patients with chronic pain
  • patients with and regular users of a smartphone
  • Non-opposition to participation in the study

Exclusion Criteria:

  • Patient unable to understand or answer questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
All patients with chronic pain follow in pain clinic
e-health program (smartphone and web platform)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the e-health tool
Time Frame: Once, up to 12 months
Feasibility evaluated by analysis of user acceptability (custom questionnaire: ease of use, utility...)
Once, up to 12 months
Feasibility of the e-health tool
Time Frame: Once, up to 12 months
Feasibility evaluated by analysis of Number of data completed / missing (% of responses)
Once, up to 12 months
Feasibility of the e-health tool
Time Frame: Once, up to 12 months
Feasibility evaluated by analysis of Participation of investigator centres (inclusion rate)
Once, up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Typology of patient responses
Time Frame: Weekly, up to 6 months
Temporal evolution of the pain intensity using 0-10 VAS
Weekly, up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
Temporal evolution of the anxiety using 0-10 VAS
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
Temporal evolution of the sleep quality using 0-10 VAS
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
Temporal evolution of the mood using 0-10 VAS
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
Temporal evolution of the body comfort using 0-10 VAS
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by Brief Pain Inventory questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by Pain Beliefs and Perceptions Inventory questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by Medical Outcomes Study-Sleep Scale questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by Tampa Scale of Kinesiophobia questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by Pain Catastrophizing Scale questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by EQ-5D questionnaire
Up to 6 months
Typology of patient responses
Time Frame: Up to 6 months
temporal evolution of the chronic pain symptoms and related-comorbidities by ,Hospital Anxiety Depression Scale questionnaire
Up to 6 months
impact of the eHealth tool
Time Frame: Once, Up to 12 months.
evaluation of the impact of the eHealth tool on current practices (clinician's opinion)
Once, Up to 12 months.
impact of the eHealth tool
Time Frame: Once, up 12 months.
evaluation of the impact of the eHealth tool on quality of life (patient's opinion)
Once, up 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Noémie DELAGE, University Hospital, Clermont-Ferrand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2019

Primary Completion (Actual)

June 4, 2020

Study Completion (Actual)

June 4, 2020

Study Registration Dates

First Submitted

February 7, 2019

First Submitted That Met QC Criteria

April 29, 2019

First Posted (Actual)

April 30, 2019

Study Record Updates

Last Update Posted (Actual)

September 21, 2020

Last Update Submitted That Met QC Criteria

September 18, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHU-425
  • 2018-A01790-5546 (Other Identifier: 2018-A01790-5546)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on e-DOL

3
Subscribe